• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMerck

Merck

0
Businesswoman leading job interview with man.
NewslettersHiring managers say they support dropping college degree requirements, but few actually do so. The reasons why might surprise you
By Ruth UmohSeptember 13, 2023
HealthOverwhelmed by a massive outbreak, China authorizes emergency use of Merck COVID pill Lagevrio
By BloombergDecember 30, 2022
FinanceThe world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By Paige McGlauflinAugust 15, 2022
CommentaryIt’s time for companies to do less
By Daryl BrewsterMay 5, 2022
Albert Bourla, chairman and chief executive officer of Pfizer Inc., speaks during South By Southwest.
HealthThe most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By Sy Mukherjee and IDEA PharmaApril 20, 2022
HealthA new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well
By Jason Gale, John Lauerman and BloombergFebruary 15, 2022
HealthNew York City will home-deliver free antiviral pills to COVID-19 patients
By Ian Fisher and BloombergJanuary 31, 2022
Merck covid 19 pill
HealthFDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
COVID-19 pill
HealthFDA set to authorize Pfizer and Merck COVID pills this week
By Josh Wingrove, Jennifer Jacobs, Robert Langreth and BloombergDecember 21, 2021
US-HEALTH-VIRUS-TREATMENT
HealthGSK says its COVID antibody therapy works against Omicron. Here’s what other drugmakers say about their treatments
By Sophie MellorDecember 7, 2021
HealthGermany will make COVID vaccinations mandatory if Angela Merkel gets her way
By Christiaan HetznerDecember 2, 2021
HealthMerck says its breakthrough COVID-19 pill doesn’t work nearly as well as previously reported
By Fiona Rutherford and BloombergNovember 26, 2021
Merck COVID-19 pill
HealthMerck says the U.S. will buy 1.4 million doses of its COVID-19 antiviral pill
By John Lauerman and BloombergNovember 9, 2021
In this photo illustration a multiple exposure image shows a Pfizer logo displayed on a smartphone with stock market percentages in the background.
HealthPfizer says its COVID pill cuts rates of death and hospitalization by 89%, sending shares skyward
By David MeyerNovember 5, 2021
HealthMerck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
By Frank Connelly and BloombergNovember 4, 2021
0
Most Popular
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
C-Suite
OpenAI’s Sam Altman says his highly disciplined daily routine has ‘fallen to crap’—and now unwinds on weekends at a ranch with no cell phone serviceAn image of a popular article
By Jacqueline MunisFebruary 5, 2026
Investing
Ray Dalio warns the world is ‘on the brink’ of a capital war of weaponizing money—and gold is the best way for people to protect themselvesAn image of a popular article
By Sasha RogelbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.